Lumos Diagnostics Holdings (ASX:LDX) Days Sales Outstanding : 157.94 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Days Sales Outstanding?

Lumos Diagnostics Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was A$3.58 Mil. Lumos Diagnostics Holdings's Revenue for the six months ended in Dec. 2023 was A$4.13 Mil. Hence, Lumos Diagnostics Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 157.94.

The historical rank and industry rank for Lumos Diagnostics Holdings's Days Sales Outstanding or its related term are showing as below:

ASX:LDX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 94.27 Med: 127.11 Max: 130.13
Current: 94.27

During the past 2 years, Lumos Diagnostics Holdings's highest Days Sales Outstanding was 130.13. The lowest was 94.27. And the median was 127.11.

ASX:LDX's Days Sales Outstanding is ranked worse than
66.51% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.88 vs ASX:LDX: 94.27

Lumos Diagnostics Holdings's Days Sales Outstanding increased from Dec. 2022 (99.73) to Dec. 2023 (157.94).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Lumos Diagnostics Holdings Days Sales Outstanding Historical Data

The historical data trend for Lumos Diagnostics Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Days Sales Outstanding Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Days Sales Outstanding

130.13

124.08

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			123.01	71.19	99.73	79.94	157.94

Competitive Comparison of Lumos Diagnostics Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Days Sales Outstanding falls into.

Lumos Diagnostics Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lumos Diagnostics Holdings's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (5.9	+	4.772)	/	2 )	/	15.697	*	365
=	5.336					/	15.697	*	365
=	124.08

Lumos Diagnostics Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.772	+	2.38)	/	2 )	/	4.132	*	365 / 2
=	3.576					/	4.132	*	365 / 2
=	157.94

Lumos Diagnostics Holdings (ASX:LDX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lumos Diagnostics Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines